“The FAST TRACK Evaluation Service has allowed us to begin clinical research projects more rapidly while still following the rigorous regulatory and ethical process which ensures patient safety. We are extremely proud of being the first site in the world to be activated for this study, which will allow Dr. Oskoui to offer this new treatment faster to her young patients.”
